| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/06/2013 | WO2013079580A1 Methods and pharmaceutical compositions for the treatment of darier disease |
| 06/06/2013 | WO2013079546A1 Topical composition containing a combination of at least one blue algae extract with at least one alpha hydroxy acid or one of the salts thereof |
| 06/06/2013 | WO2013079505A1 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/06/2013 | WO2013079501A1 Crystalline dapagliflozin hydrate |
| 06/06/2013 | WO2013079495A1 2-(phenyl or pyrid-3-yl) aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | WO2013079494A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | WO2013079460A1 Novel compounds |
| 06/06/2013 | WO2013079452A1 New bicyclic dihydroisoquinoline-1-one derivatives |
| 06/06/2013 | WO2013079425A1 Novel 2h-indazoles as ep2 receptor antagonists |
| 06/06/2013 | WO2013079407A1 Aryl derivatives for controlling ectoparasites |
| 06/06/2013 | WO2013079394A1 Increasing the bioavailability of hydroxycinnamic acids |
| 06/06/2013 | WO2013079386A1 Transdermal therapeutic system for administering fentanyl or an analogue thereof |
| 06/06/2013 | WO2013079223A1 Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rorϒ, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases |
| 06/06/2013 | WO2013079211A1 Use of pegylated alcohols for the treatment of actinic keratosis |
| 06/06/2013 | WO2013079205A1 Low dose therapeutic use of glyceryl tri-(4-phenylbutyrate) |
| 06/06/2013 | WO2013079040A1 Mixed solvate of tiotropium bromide and a method of its preparation |
| 06/06/2013 | WO2013079024A1 Oleanolic acid amidate derivatives, preparation methods and uses thereof |
| 06/06/2013 | WO2013079022A1 2-aminated methylene or 2-esterified methylene tanshinone derivatives, and preparation method and application thereof |
| 06/06/2013 | WO2013079018A1 2-substituted oleanolic acid derivative, method preparing for same, and application thereof |
| 06/06/2013 | WO2013079017A1 2-alkyl-or-aryl-substituted tanshinone derivatives, and preparation method and application thereof |
| 06/06/2013 | WO2013079007A1 Donepezil pamoate, preparation methode and its use |
| 06/06/2013 | WO2013078998A1 Novel slow-releasing ophthalmic compositions comprising povidone iodine |
| 06/06/2013 | WO2013078983A1 Sodium Piperonyl Pentadienoate and Use of the Same for Lowering Blood Lipid |
| 06/06/2013 | WO2013078973A1 Large particle diameter dasatinib and preparation and use thereof |
| 06/06/2013 | WO2013078771A1 Poly (adp-ribose) polymerase inhibitor |
| 06/06/2013 | WO2013078769A1 Conjugate of polyethylene glycol and tamsulosin and pharmaceutical composition thereof |
| 06/06/2013 | WO2013078765A1 Thienyl [3, 2-d] pyrimidin-4-one compounds, preparation method, pharmaceutical compositions and use thereof |
| 06/06/2013 | WO2013078764A1 Applications of 1β-hydroxy isoalantolactone in preparing medicines against rheumatoid arthritis |
| 06/06/2013 | WO2013078754A1 Promoting hair growth solution containing chlorine dioxide， preparation method and use method thereof |
| 06/06/2013 | WO2013078658A1 Morus berries and avoiding glucose peaks |
| 06/06/2013 | WO2013078608A1 Donepezil pamoate and methods of making and using the same |
| 06/06/2013 | WO2013078554A1 Compositions of tigecycline and uses thereof |
| 06/06/2013 | WO2013078550A1 Use of pullulan for alleviating the appearance of scars or scar tissue |
| 06/06/2013 | WO2013078544A1 Heterocyclic amides compounds which are hdac6 inhibitors and used as anti-tumoral agents |
| 06/06/2013 | WO2013078540A1 Prophylactic compositions for management of microbial infections in patients with brain injury |
| 06/06/2013 | WO2013078523A1 Heterocyclic n-glycinyl-n-acyl hydrazone compounds, synthesis method, pharmaceutical compositions and treatment method |
| 06/06/2013 | WO2013078500A1 Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug |
| 06/06/2013 | WO2013061101A9 Primycin and components thereof for use in the treatment or prevention of infections caused by specific pathogens |
| 06/06/2013 | WO2013059548A9 Compositions and methods for treating cancer using jak2 inhibitor |
| 06/06/2013 | WO2013057337A3 Composition capable of promoting the proliferation of neural stem cells |
| 06/06/2013 | WO2013057251A3 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 06/06/2013 | WO2013055913A3 Pgam1 inhibitors and methods related thereto |
| 06/06/2013 | WO2013055258A3 Use of glutaryl histamine to treat respiratory tract infections |
| 06/06/2013 | WO2013052699A3 Novel quinoxaline inhibitors of pi3k |
| 06/06/2013 | WO2013051883A3 Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein |
| 06/06/2013 | WO2013049726A3 Processes for making compounds useful as inhibitors of atr kinase |
| 06/06/2013 | WO2013049521A3 Light-enabled drug delivery |
| 06/06/2013 | WO2013045330A3 Deodorant comprising dimethyl isosorbide |
| 06/06/2013 | WO2013043744A3 Tricyclic compounds useful as neurogenic and neuroprotective agents |
| 06/06/2013 | WO2013041963A3 A composition and method for treating an autoimmune disease |
| 06/06/2013 | WO2013033407A3 Identification of small molecules that enhance therapeutic exon skipping |
| 06/06/2013 | WO2013033037A3 Novel antiprion compounds |
| 06/06/2013 | WO2013024040A3 Tnf superfamily trimerization inhibitors |
| 06/06/2013 | WO2013019917A3 Permanent attachment of ammonium and guanidine-based antimicrobials to surfaces containing c-h functionality |
| 06/06/2013 | WO2013019857A3 Method for improving the success rate of hematopoietic stem cell transplants |
| 06/06/2013 | WO2013019733A3 Methods, compositions and kits for therapeutic treatment with wet spun microstructures |
| 06/06/2013 | WO2013019623A3 Methods and compositions for modulating the innate immune response and/or myogenesis in a mammalian subject |
| 06/06/2013 | WO2013014654A4 Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis |
| 06/06/2013 | WO2013012771A3 Clinical applications of a recombinant human endostatin adenovirus (e10a) injection |
| 06/06/2013 | WO2012150183A8 Crystalline sodium salt of an hiv integrase inhibitor |
| 06/06/2013 | WO2012083185A8 Peptide-based in vivo sirna delivery system |
| 06/06/2013 | WO2012074126A9 Bicyclic compound |
| 06/06/2013 | WO2012059724A8 Formulations comprising polyethylene glycol |
| 06/06/2013 | US20130144062 Heteroaryl carboxamides |
| 06/06/2013 | US20130144059 Use of pdgf-r inhibitors for the treatment of lymph node metastasis of gastric cancer |
| 06/06/2013 | US20130144058 Process for the synthesis of carbonucleoside and intermediates for use therein |
| 06/06/2013 | US20130144056 Human Adam-10 Inhibitors |
| 06/06/2013 | US20130144050 Crystal form of 4-isopropylphenyl glucitol compound and process for production thereof |
| 06/06/2013 | US20130144014 Multi-arm block copolymers as drug delivery vehicles |
| 06/06/2013 | US20130143970 Medicinal preparation particularly for the treatment of slipped discs hernias |
| 06/06/2013 | US20130143969 Curcumin compositions and uses thereof |
| 06/06/2013 | US20130143968 Methods and compositions for the treatment of diabetes and related symtoms |
| 06/06/2013 | US20130143967 Organosulfur compounds for the prevention and treatment of neurodegenerative diseases |
| 06/06/2013 | US20130143966 Methods of treatment using sterculic acid |
| 06/06/2013 | US20130143965 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 06/06/2013 | US20130143964 Sympathetic inhibitor, and cosmetic composition, food, and sundry article containing the same |
| 06/06/2013 | US20130143962 Adamantyl Derivatives as Therapeutic Agents |
| 06/06/2013 | US20130143961 Anti-viral carbamimidothioic acid esters |
| 06/06/2013 | US20130143960 Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity |
| 06/06/2013 | US20130143959 Extracts with liver-x-receptor modulators, compounds and their use especially in weight control |
| 06/06/2013 | US20130143958 Dosage unit comprising a prostaglandin analog for treating constipation |
| 06/06/2013 | US20130143957 Polymorphic forms of warfarin potassium and preparations thereof |
| 06/06/2013 | US20130143956 Long-acting injectable moxidectin formulations and novel moxidectin crystal forms |
| 06/06/2013 | US20130143955 Cyclic di-GMP-II Riboswitches, Motifs, and Compounds, and Methods for Their Use |
| 06/06/2013 | US20130143950 Compounds and Methods for the Treatment of Cancer |
| 06/06/2013 | US20130143947 Injectable Pharmaceutical Composition for Preventing, Stabilising and/or Inhibiting Pathological Neovascularization-Related Conditions |
| 06/06/2013 | US20130143946 Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg |
| 06/06/2013 | US20130143944 Chemo- and radiation-sensitization of cancer by antisense trpm-2 oligodeoxynucleotides |
| 06/06/2013 | US20130143941 Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
| 06/06/2013 | US20130143938 Compositions and Methods for the Treatment of Migraine |
| 06/06/2013 | US20130143937 Chlorthalidone combinations |
| 06/06/2013 | US20130143934 Agent for regeneration and/or protection of nerves |
| 06/06/2013 | US20130143933 Targeted correction of a genetic defect in cancer therapy |
| 06/06/2013 | US20130143932 Optical enantiomers of phenyramidol and process for chiral synthesis |
| 06/06/2013 | US20130143930 Activation of amp-protein activated kinase by oxaloacetate compounds |
| 06/06/2013 | US20130143928 Bis-pyrinidium compounds |
| 06/06/2013 | US20130143927 Compounds that modulate intracellular calcium |
| 06/06/2013 | US20130143923 Crystalline forms of thalidomide and processes for their preparation |
| 06/06/2013 | US20130143922 Thio compounds |
| 06/06/2013 | US20130143921 Novel peperidine-flavan alkaloid compounds derived from african herb tea kinkeliba as anti-diabetic agents |